ANTICOAGULANT SOLUTION CITRATE PHOSPHATE DEXTROSE (CPD)
ANTICOAGULANT SOLUTION CITRATE PHOSPHATE DEXTROSE (CPD)
Approved
DIN Number
02444100
Drug Class
Human
Market Date
Aug 22, 2016
Company
HC
maco pharma
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02444100
AIG Number0457190001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Product Specifications
Dosage FormSolution
Route of Administration0-Unassigned
AHFS Classification20:12.04.92
Health Canada Classification
ACTIVE INGREDIENTS (4)
CITRIC ACIDActive
Strength: 3.27 G / L
Monograph: CITRIC ACID
DEXTROSEActive
Strength: 25.5 G / L
Monograph: DEXTROSE
SODIUM CITRATE DIHYDRATEActive
Strength: 26.3 G / L
Monograph: SODIUM CITRATE DIHYDRATE
SODIUM PHOSPHATE MONOBASICActive
Strength: 2.51 G / L
Monograph: SODIUM PHOSPHATE MONOBASIC